Syros Pharmaceuticals Inc (SYRS)
5.80
-0.01
(-0.17%)
USD |
NASDAQ |
Jun 25, 16:00
5.80
0.00 (0.00%)
After-Hours: 20:00
Syros Pharmaceuticals Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 41.22M |
September 30, 2023 | 41.07M |
June 30, 2023 | 40.93M |
March 31, 2023 | 40.78M |
December 31, 2022 | 40.65M |
September 30, 2022 | 40.51M |
June 30, 2022 | 40.64M |
March 31, 2022 | 40.44M |
December 31, 2021 | 40.26M |
September 30, 2021 | 40.07M |
June 30, 2021 | 39.89M |
March 31, 2021 | 39.72M |
December 31, 2020 | 39.55M |
September 30, 2020 | 19.72M |
June 30, 2020 | 19.64M |
March 31, 2020 | 19.57M |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
Date | Value |
---|---|
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
41.22M
Maximum
Dec 2023
30.77M
Average
40.07M
Median
Sep 2021
Total Long Term Debt (Quarterly) Benchmarks
PDS Biotechnology Corp | -- |
PAVmed Inc | 45.54M |
Moderna Inc | 0.00 |
Altimmune Inc | 0.00 |
iBio Inc | -- |